US OptionsDetailed Quotes

LYRA250516C5000

Watchlist

0.80
0.000.00%

15min DelayClose May 9 16:00 ET

0.00High0.00Low

Lyra Therapeutics Stock Discussion

FattyChick

May 7 21:59

$Lyra Therapeutics (LYRA.US)$ Nice back to back pump on biotech tickers.

Teddy123

May 7 19:32

Lyra Therapeutics to Present 52-week Extension Stage Results for ENLIGHTEN 1 Phase 3 Study for LYR-210 for the Treatment of Chronic Rhinosinusitis at COSM 2025

$Lyra Therapeutics (LYRA.US)$
Lyra Therapeutics to Present 52-week Extension Stage Results for ENLIGHTEN 1 Phase 3 Study for LYR-210 for the Treatment of Chronic Rhinosinusitis at COSM 2025

Trytosaveabit

May 7 04:13

Make a note! R/S should be before Data?

$Lyra Therapeutics (LYRA.US)$ Upcoming milestones for ongoing ENLIGHTEN pivotal program of LYR-210 in CRS
•Topline results from the ENLIGHTEN 2 pivotal Phase 3 clinical trial of LYR‑210 in CRS patients are expected in Q2 2025.•We expect an additional ~30 polyp patients in the ENLIGHTEN 2 trial, which combined with the 35 polyp patients in the ENLIGHTEN 1 trial, would result in a total of ~65 polyp patients in the ENLIGHTEN program.
The ENLIGHTEN program cons...